CD164及其他近期发现的激活标志物有望成为过敏诊断的工具：有哪些新进展？ - Suppr

Suppr

超能文献

CD164 and other recently discovered activation markers as promising tools for allergy diagnosis: what's new?

作者信息

Chirumbolo Salvatore

出版信息

Clin Exp Med. 2011 Dec;11(4):255-7. doi: 10.1007/s10238-011-0132-y. Epub 2011 Apr 2.

DOI:10.1007/s10238-011-0132-y

PMID:21461759

Abstract

摘要

相似文献

CD164 and other recently discovered activation markers as promising tools for allergy diagnosis: what's new?

Clin Exp Med. 2011 Dec;11(4):255-7. doi: 10.1007/s10238-011-0132-y. Epub 2011 Apr 2.

In vitro allergy diagnosis: should we follow the flow?

Clin Exp Allergy. 2004 Mar;34(3):332-9. doi: 10.1111/j.1365-2222.2004.01891.x.

Sceptical views on homeopathy: Do we really need "sceptical" homeopaths?

Homeopathy. 2010 Oct;99(4):289; author reply 289. doi: 10.1016/j.homp.2010.08.008.

[Using flow cytometry in laboratory diagnosis of allergic diseases].

Pneumonol Alergol Pol. 2006;74(2):239-41.

For allergy diagnostic flow cytometry, detection of CD203c instead of CD63 is not at all an improvement in other hands.

Clin Exp Allergy. 2003 Jun;33(6):849-52; author reply 852-3.

CD164 as a Basophil Activation Marker.

Curr Pharm Des. 2011 Nov;17(34):3786-96. doi: 10.2174/138161211798357890.

Lack of basophil CD203c-upregulating activity as an immunological marker to predict response to treatment with omalizumab in patients with symptomatic chronic urticaria.

J Allergy Clin Immunol Pract. 2016 May-Jun;4(3):529-30. doi: 10.1016/j.jaip.2015.11.025. Epub 2015 Dec 24.

Comments regarding 'Marked improvement of the basophil activation test by detecting CD203c instead of CD63' by Boumiza et al.

Clin Exp Allergy. 2003 Jun;33(6):849; author reply 852-3.

In vitro assays for the diagnosis of IgE-mediated disorders.

J Allergy Clin Immunol. 2004 Aug;114(2):213-25; quiz 226. doi: 10.1016/j.jaci.2004.06.046.

Basophil activation test based on the expression of CD203c in the diagnostics of cow milk allergy in children.

Eur J Med Res. 2010 Nov 4;15 Suppl 2(Suppl 2):21-6. doi: 10.1186/2047-783x-15-s2-21.

引用本文的文献

Identification of new cancer stem cell markers and signaling pathways in HER‑2‑positive breast cancer by transcriptome sequencing.

Int J Oncol. 2019 Nov;55(5):1003-1018. doi: 10.3892/ijo.2019.4876. Epub 2019 Sep 12.

CD164 promotes tumor progression and predicts the poor prognosis of bladder cancer.

Cancer Med. 2018 Aug;7(8):3763-3772. doi: 10.1002/cam4.1607. Epub 2018 Jul 18.

CD164 regulates proliferation and apoptosis by targeting PTEN in human glioma.

Mol Med Rep. 2017 Apr;15(4):1713-1721. doi: 10.3892/mmr.2017.6204. Epub 2017 Feb 15.

Immunotherapy in allergy and cellular tests: state of art.

Hum Vaccin Immunother. 2014;10(6):1595-610. doi: 10.4161/hv.28592. Epub 2014 May 2.

Monitoring of CD63% in basophil activation test and suggested new parameters for allergy diagnosis.

Inflamm Res. 2012 Feb;61(2):171-6. doi: 10.1007/s00011-011-0416-4. Epub 2011 Dec 29.

本文引用的文献

CCR3 as a single selection marker compared to CD123/HLADR to isolate basophils in flow cytometry: some comments.

Cytometry A. 2011 Feb;79(2):102-6. doi: 10.1002/cyto.a.21008. Epub 2010 Dec 30.

Risk factors and asthma phenotypes in children and adults with seasonal allergic rhinitis.

Phys Sportsmed. 2010 Dec;38(4):81-6. doi: 10.3810/psm.2010.12.1829.

Objective measurements using the skin prick test in allergic rhinitis.

Arch Otolaryngol Head Neck Surg. 2010 Nov;136(11):1104-6. doi: 10.1001/archoto.2010.185.

Validation of basophil CD164 upregulation for pollen allergy diagnosis.

Arch Immunol Ther Exp (Warsz). 2010 Dec;58(6):459-65. doi: 10.1007/s00005-010-0104-z. Epub 2010 Sep 28.

The use of IL-3 in basophil activation tests is the real pitfall.

Cytometry B Clin Cytom. 2011 Mar;80(2):137-8; author reply 139. doi: 10.1002/cyto.b.20570. Epub 2010 Sep 15.

Robust expression of CCR3 as a single basophil selection marker in flow cytometry.

Allergy. 2011 Jan;66(1):85-91. doi: 10.1111/j.1398-9995.2010.02431.x.

[Allergy diagnosis by primary care physicians].

Rev Med Suisse. 2010 Apr 21;6(245):812, 814-6.

Basophil sensitivity through CD63 or CD203c is a functional measure for specific immunotherapy.

Clin Mol Allergy. 2010 Feb 16;8(1):2. doi: 10.1186/1476-7961-8-2.

Update on the medical treatment of allergic rhinitis.

Inflamm Allergy Drug Targets. 2009 Jun;8(2):96-103. doi: 10.2174/187152809788462653.

Biomarkers for allergen immunotherapy in cedar pollinosis.

Allergol Int. 2009 Jun;58(2):163-70. doi: 10.2332/allergolint.09-RAI-0097. Epub 2009 Apr 25.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

CD164 and other recently discovered activation markers as promising tools for allergy diagnosis: what's new?

Clin Exp Med. 2011 Dec;11(4):255-7. doi: 10.1007/s10238-011-0132-y. Epub 2011 Apr 2.

In vitro allergy diagnosis: should we follow the flow?

Clin Exp Allergy. 2004 Mar;34(3):332-9. doi: 10.1111/j.1365-2222.2004.01891.x.

Sceptical views on homeopathy: Do we really need "sceptical" homeopaths?

Homeopathy. 2010 Oct;99(4):289; author reply 289. doi: 10.1016/j.homp.2010.08.008.

[Using flow cytometry in laboratory diagnosis of allergic diseases].

Pneumonol Alergol Pol. 2006;74(2):239-41.

For allergy diagnostic flow cytometry, detection of CD203c instead of CD63 is not at all an improvement in other hands.

Clin Exp Allergy. 2003 Jun;33(6):849-52; author reply 852-3.

CD164 as a Basophil Activation Marker.

Curr Pharm Des. 2011 Nov;17(34):3786-96. doi: 10.2174/138161211798357890.

Lack of basophil CD203c-upregulating activity as an immunological marker to predict response to treatment with omalizumab in patients with symptomatic chronic urticaria.

J Allergy Clin Immunol Pract. 2016 May-Jun;4(3):529-30. doi: 10.1016/j.jaip.2015.11.025. Epub 2015 Dec 24.

Comments regarding 'Marked improvement of the basophil activation test by detecting CD203c instead of CD63' by Boumiza et al.

Clin Exp Allergy. 2003 Jun;33(6):849; author reply 852-3.

In vitro assays for the diagnosis of IgE-mediated disorders.

J Allergy Clin Immunol. 2004 Aug;114(2):213-25; quiz 226. doi: 10.1016/j.jaci.2004.06.046.

Basophil activation test based on the expression of CD203c in the diagnostics of cow milk allergy in children.

Eur J Med Res. 2010 Nov 4;15 Suppl 2(Suppl 2):21-6. doi: 10.1186/2047-783x-15-s2-21.

引用本文的文献

Identification of new cancer stem cell markers and signaling pathways in HER‑2‑positive breast cancer by transcriptome sequencing.

Int J Oncol. 2019 Nov;55(5):1003-1018. doi: 10.3892/ijo.2019.4876. Epub 2019 Sep 12.

CD164 promotes tumor progression and predicts the poor prognosis of bladder cancer.

Cancer Med. 2018 Aug;7(8):3763-3772. doi: 10.1002/cam4.1607. Epub 2018 Jul 18.

CD164 regulates proliferation and apoptosis by targeting PTEN in human glioma.

Mol Med Rep. 2017 Apr;15(4):1713-1721. doi: 10.3892/mmr.2017.6204. Epub 2017 Feb 15.

Immunotherapy in allergy and cellular tests: state of art.

Hum Vaccin Immunother. 2014;10(6):1595-610. doi: 10.4161/hv.28592. Epub 2014 May 2.

Monitoring of CD63% in basophil activation test and suggested new parameters for allergy diagnosis.

Inflamm Res. 2012 Feb;61(2):171-6. doi: 10.1007/s00011-011-0416-4. Epub 2011 Dec 29.

本文引用的文献

CCR3 as a single selection marker compared to CD123/HLADR to isolate basophils in flow cytometry: some comments.

Cytometry A. 2011 Feb;79(2):102-6. doi: 10.1002/cyto.a.21008. Epub 2010 Dec 30.

Risk factors and asthma phenotypes in children and adults with seasonal allergic rhinitis.

Phys Sportsmed. 2010 Dec;38(4):81-6. doi: 10.3810/psm.2010.12.1829.

Objective measurements using the skin prick test in allergic rhinitis.

Arch Otolaryngol Head Neck Surg. 2010 Nov;136(11):1104-6. doi: 10.1001/archoto.2010.185.

Validation of basophil CD164 upregulation for pollen allergy diagnosis.

Arch Immunol Ther Exp (Warsz). 2010 Dec;58(6):459-65. doi: 10.1007/s00005-010-0104-z. Epub 2010 Sep 28.

The use of IL-3 in basophil activation tests is the real pitfall.

Cytometry B Clin Cytom. 2011 Mar;80(2):137-8; author reply 139. doi: 10.1002/cyto.b.20570. Epub 2010 Sep 15.

Robust expression of CCR3 as a single basophil selection marker in flow cytometry.

Allergy. 2011 Jan;66(1):85-91. doi: 10.1111/j.1398-9995.2010.02431.x.

[Allergy diagnosis by primary care physicians].

Rev Med Suisse. 2010 Apr 21;6(245):812, 814-6.

Basophil sensitivity through CD63 or CD203c is a functional measure for specific immunotherapy.

Clin Mol Allergy. 2010 Feb 16;8(1):2. doi: 10.1186/1476-7961-8-2.

Update on the medical treatment of allergic rhinitis.

Inflamm Allergy Drug Targets. 2009 Jun;8(2):96-103. doi: 10.2174/187152809788462653.

Biomarkers for allergen immunotherapy in cedar pollinosis.

Allergol Int. 2009 Jun;58(2):163-70. doi: 10.2332/allergolint.09-RAI-0097. Epub 2009 Apr 25.